Norris Turner Abigail, Carr Reese Patricia, Snead Margaret Christine, Fields Karen, Ervin Melissa, Kourtis Athena P, Klebanoff Mark A, Gallo Maria F
From the *Division of Infectious Diseases, College of Medicine, Ohio State University, Columbus, OH; †School of Medicine and Health Sciences, George Washington University, Washington, DC; ‡Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA; §Sexual Health Clinic, Columbus Public Health, Columbus, OH; ¶The Research Institute at Nationwide Children's Hospital, Columbus, OH; and ∥Department of Pediatrics, Ohio State University, Columbus, OH; and **Division of Epidemiology, College of Public Health, Ohio State University, Columbus, OH.
Sex Transm Dis. 2016 Mar;43(3):172-6. doi: 10.1097/OLQ.0000000000000414.
Self-reported unprotected vaginal sex seems to increase risk of bacterial vaginosis (BV). However, the validity of self-reports is questionable, given their inconsistency with more objective measures of recent semen exposure such as detection of prostate-specific antigen (PSA). We examined whether recent unprotected sex, as measured both by PSA detection on vaginal swabs and by self-report, was associated with increased BV recurrence.
We analyzed randomized trial data from nonpregnant, BV-positive adult women recruited from a sexually transmitted disease clinic. Participants received BV therapy at enrollment and were scheduled to return after 4, 12, and 24 weeks. Bacterial vaginosis (by Nugent score) and PSA were measured at each visit. We used Cox proportional hazards models to examine the association between PSA positivity and recurrent BV. We also evaluated associations between self-reported unprotected sex (ever/never since the last visit and in the last 48 hours, analyzed separately) and recurrent BV.
Prostate-specific antigen and BV results were available for 96 women who contributed 226 follow-up visits. Prostate-specific antigen positivity was associated with increased BV recurrence (adjusted hazard ratio [aHR], 2.32; 95% confidence interval [CI], 1.28-4.21). In contrast, we observed no significant increase in BV recurrence among women self-reporting unprotected sex since the last visit (aHR, 1.63; 95% CI, 0.77-3.43) or in the last 48 hours (aHR, 1.28; 95% CI, 0.70-2.36).
Estimates from earlier studies linking self-reported unprotected sex and BV may be biased by misclassification. Biomarkers can improve measurement of unprotected sex, a critical exposure variable in sexual health research.
自我报告的无保护阴道性行为似乎会增加细菌性阴道病(BV)的风险。然而,鉴于自我报告与近期精液暴露的更客观测量方法(如前列腺特异性抗原(PSA)检测)不一致,其有效性值得怀疑。我们研究了通过阴道拭子PSA检测和自我报告测量的近期无保护性行为是否与BV复发增加有关。
我们分析了从性传播疾病诊所招募的非妊娠、BV阳性成年女性的随机试验数据。参与者在入组时接受BV治疗,并计划在4周、12周和24周后返回。每次就诊时测量细菌性阴道病(通过Nugent评分)和PSA。我们使用Cox比例风险模型来检查PSA阳性与复发性BV之间的关联。我们还评估了自我报告的无保护性行为(自上次就诊以来/从未以及在过去48小时内,分别分析)与复发性BV之间的关联。
96名女性提供了226次随访就诊,可获得前列腺特异性抗原和BV结果。前列腺特异性抗原阳性与BV复发增加相关(调整后的风险比[aHR],2.32;95%置信区间[CI],1.28 - 4.21)。相比之下,我们观察到自上次就诊以来自我报告有无保护性行为的女性(aHR,1.63;95% CI,0.77 - 3.43)或在过去48小时内(aHR,1.28;95% CI,0.70 - 2.36)的BV复发没有显著增加。
早期研究中关于自我报告的无保护性行为与BV之间联系的估计可能因错误分类而存在偏差。生物标志物可以改善无保护性行为的测量,这是性健康研究中的一个关键暴露变量。